Elliot Ehrich Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Elliot Ehrich.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elliot Ehrich. Elliot Ehrich is SVP, R&D & Chief Medical Ofcr in ALKERMES INC ($ALKS) and VP, Science and Development in ALKERMES INC ($ALKS) and EVP, R&D & CMO, Alkermes, Inc. in Alkermes plc. ($ALKS).
Latest Insider Trading Transactions of Elliot Ehrich
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
| May 30 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 57.70 | 1,765 | 101,841 | 57,056 | 58.8 K to 57.1 K (-3.00 %) |
| May 30 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 58,821 | 55.1 K to 58.8 K (+6.81 %) |
| Apr 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 9,801 | |
| Apr 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 56.60 | 10,000 | 565,986 | 55,071 | 65.1 K to 55.1 K (-15.37 %) |
| Apr 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 10,000 | 165,500 | 65,071 | 55.1 K to 65.1 K (+18.16 %) |
| Mar 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 19,801 | |
| Mar 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 57.00 | 6,900 | 393,321 | 55,071 | 62 K to 55.1 K (-11.13 %) |
| Mar 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 56.29 | 4,100 | 230,787 | 61,971 | 66.1 K to 62 K (-6.21 %) |
| Mar 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 10,000 | 165,500 | 66,071 | 56.1 K to 66.1 K (+17.83 %) |
| Mar 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 3,750 | |
| Mar 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 60.97 | 1,765 | 107,612 | 56,071 | 57.8 K to 56.1 K (-3.05 %) |
| Mar 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 57,836 | 54.1 K to 57.8 K (+6.93 %) |
| Feb 27 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
| Feb 27 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 52.98 | 1,765 | 93,510 | 51,042 | 52.8 K to 51 K (-3.34 %) |
| Feb 27 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 52,807 | 49.1 K to 52.8 K (+7.64 %) |
| Feb 21 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 54.57 | 65,000 | 3,547,050 | 65,000 | |
| Feb 21 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Feb 21 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Gift | G | 0.00 | 600 | 0 | 49,057 | 49.7 K to 49.1 K (-1.21 %) |
| Feb 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 29,801 | |
| Feb 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 56.84 | 6,085 | 345,854 | 49,657 | 55.7 K to 49.7 K (-10.92 %) |
| Feb 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 56.05 | 3,915 | 219,418 | 55,742 | 59.7 K to 55.7 K (-6.56 %) |
| Feb 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 10,000 | 165,500 | 59,657 | 49.7 K to 59.7 K (+20.14 %) |
| Feb 16 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 58.17 | 1,000 | 58,170 | 49,657 | 50.7 K to 49.7 K (-1.97 %) |
| Jan 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 39,801 | |
| Jan 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 54.32 | 11,983 | 650,945 | 50,657 | 62.6 K to 50.7 K (-19.13 %) |
| Jan 18 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 10,000 | 165,500 | 62,640 | 52.6 K to 62.6 K (+19.00 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 2,100 | 38,021 | 6,000 | |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 400 | 7,242 | 8,100 | |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 7,500 | 135,788 | 8,500 | |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 60.12 | 2,100 | 126,246 | 52,640 | 54.7 K to 52.6 K (-3.84 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 2,100 | 38,021 | 54,740 | 52.6 K to 54.7 K (+3.99 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 60.08 | 400 | 24,031 | 52,640 | 53 K to 52.6 K (-0.75 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 400 | 7,242 | 53,040 | 52.6 K to 53 K (+0.76 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 60.01 | 2,500 | 150,022 | 52,640 | 55.1 K to 52.6 K (-4.53 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 58.83 | 5,000 | 294,126 | 55,140 | 60.1 K to 55.1 K (-8.31 %) |
| Jan 06 2017 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 7,500 | 135,788 | 60,140 | 52.6 K to 60.1 K (+14.25 %) |
| Dec 15 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 5,000 | 90,525 | 16,000 | |
| Dec 15 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 55.99 | 5,000 | 279,963 | 52,640 | 57.6 K to 52.6 K (-8.67 %) |
| Dec 15 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 5,000 | 90,525 | 57,640 | 52.6 K to 57.6 K (+9.50 %) |
| Dec 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 5,000 | 90,525 | 21,000 | |
| Dec 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 10,000 | 165,500 | 49,801 | |
| Dec 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 55.15 | 16,983 | 936,631 | 52,640 | 69.6 K to 52.6 K (-24.39 %) |
| Dec 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 5,000 | 90,525 | 69,623 | 64.6 K to 69.6 K (+7.74 %) |
| Dec 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 10,000 | 165,500 | 64,623 | 54.6 K to 64.6 K (+18.31 %) |
| Nov 08 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 11.74 | 8,517 | 99,990 | 0 | |
| Nov 08 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 53.97 | 1,852 | 99,952 | 54,623 | 56.5 K to 54.6 K (-3.28 %) |
| Nov 08 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 11.74 | 8,517 | 99,990 | 56,475 | 48 K to 56.5 K (+17.76 %) |
| Oct 06 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| Oct 06 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 46.43 | 2,353 | 109,250 | 47,958 | 50.3 K to 48 K (-4.68 %) |
| Oct 06 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 5,000 | 0 | 50,311 | 45.3 K to 50.3 K (+11.03 %) |
| Sep 22 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 3,834 | 69,415 | 26,000 | |
| Sep 22 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 1,166 | 21,110 | 29,834 | |
| Sep 22 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 50.84 | 3,834 | 194,926 | 45,311 | 49.1 K to 45.3 K (-7.80 %) |
| Sep 22 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 3,834 | 69,415 | 49,145 | 45.3 K to 49.1 K (+8.46 %) |
| Sep 22 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 50.81 | 1,166 | 59,242 | 45,311 | 46.5 K to 45.3 K (-2.51 %) |
| Sep 22 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 1,166 | 21,110 | 46,477 | 45.3 K to 46.5 K (+2.57 %) |
| Sep 19 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 5,000 | 90,525 | 31,000 | |
| Sep 19 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 48.87 | 5,000 | 244,331 | 45,311 | 50.3 K to 45.3 K (-9.94 %) |
| Sep 19 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 5,000 | 90,525 | 50,311 | 45.3 K to 50.3 K (+11.03 %) |
| Sep 07 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 10,000 | 181,050 | 36,000 | |
| Sep 07 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 46.31 | 2,500 | 115,782 | 45,311 | 47.8 K to 45.3 K (-5.23 %) |
| Sep 07 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 45.93 | 7,500 | 344,453 | 47,811 | 55.3 K to 47.8 K (-13.56 %) |
| Sep 07 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 10,000 | 181,050 | 55,311 | 45.3 K to 55.3 K (+22.07 %) |
| Jul 28 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 34,399 | 569,303 | 59,801 | |
| Jul 28 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 800 | 13,240 | 94,200 | |
| Jul 28 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 51.95 | 34,399 | 1,787,076 | 45,311 | 79.7 K to 45.3 K (-43.16 %) |
| Jul 28 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 34,399 | 569,303 | 79,710 | 45.3 K to 79.7 K (+75.92 %) |
| Jul 28 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 51.82 | 800 | 41,455 | 45,311 | 46.1 K to 45.3 K (-1.73 %) |
| Jul 28 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 800 | 13,240 | 46,111 | 45.3 K to 46.1 K (+1.77 %) |
| Jun 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 3,750 | |
| Jun 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 46.13 | 1,765 | 81,419 | 45,311 | 47.1 K to 45.3 K (-3.75 %) |
| Jun 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 47,076 | 43.3 K to 47.1 K (+8.66 %) |
| May 23 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 4,500 | 0 | 0 | |
| May 23 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 42.98 | 2,118 | 91,032 | 43,326 | 45.4 K to 43.3 K (-4.66 %) |
| May 23 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 4,500 | 0 | 45,444 | 40.9 K to 45.4 K (+10.99 %) |
| Mar 04 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
| Mar 04 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 32.91 | 1,217 | 40,051 | 40,944 | 42.2 K to 40.9 K (-2.89 %) |
| Mar 04 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 42,161 | 38.4 K to 42.2 K (+9.76 %) |
| Mar 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 0.00 | 23,000 | 0 | 23,000 | |
| Mar 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 32.27 | 100,000 | 3,227,000 | 100,000 | |
| Mar 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Mar 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 33.61 | 1,217 | 40,903 | 38,411 | 39.6 K to 38.4 K (-3.07 %) |
| Mar 01 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 39,628 | 35.9 K to 39.6 K (+10.45 %) |
| Apr 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 8.55 | 11,698 | 100,018 | 0 | |
| Apr 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 38.44 | 500 | 19,220 | 40,944 | 41.4 K to 40.9 K (-1.21 %) |
| Apr 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 37.63 | 11,198 | 421,376 | 41,444 | 52.6 K to 41.4 K (-21.27 %) |
| Apr 13 2016 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 8.55 | 11,698 | 100,018 | 52,642 | 40.9 K to 52.6 K (+28.57 %) |
| Nov 04 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 20.79 | 2,687 | 55,863 | 0 | |
| Nov 04 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 73.96 | 755 | 55,840 | 35,878 | 36.6 K to 35.9 K (-2.06 %) |
| Nov 04 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 20.79 | 2,687 | 55,863 | 36,633 | 33.9 K to 36.6 K (+7.92 %) |
| Oct 07 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Oct 07 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 59.77 | 2,356 | 140,818 | 33,946 | 36.3 K to 33.9 K (-6.49 %) |
| Oct 07 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Grant | A | 0.00 | 5,000 | 0 | 36,302 | 31.3 K to 36.3 K (+15.97 %) |
| May 29 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 7,500 | |
| May 29 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 59.92 | 1,767 | 105,879 | 31,302 | 33.1 K to 31.3 K (-5.34 %) |
| May 29 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 33,069 | 29.3 K to 33.1 K (+12.79 %) |
| May 22 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 4,500 | 0 | 4,500 | |
| May 22 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
| May 22 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 61.80 | 2,120 | 131,016 | 29,319 | 31.4 K to 29.3 K (-6.74 %) |
| May 22 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 4,500 | 0 | 31,439 | 26.9 K to 31.4 K (+16.70 %) |
| May 22 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 62.10 | 1,767 | 109,731 | 26,939 | 28.7 K to 26.9 K (-6.16 %) |
| May 22 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 28,706 | 25 K to 28.7 K (+15.03 %) |
| Apr 23 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 16.55 | 25,000 | 413,750 | 95,000 | |
| Apr 23 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 62.66 | 14,772 | 925,622 | 24,956 | 39.7 K to 25 K (-37.18 %) |
| Apr 23 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 61.99 | 10,228 | 634,021 | 39,728 | 50 K to 39.7 K (-20.47 %) |
| Apr 23 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 16.55 | 25,000 | 413,750 | 49,956 | 25 K to 50 K (+100.18 %) |
| Mar 17 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 18.11 | 18,000 | 325,890 | 46,000 | |
| Mar 17 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Sell | S | 66.81 | 18,000 | 1,202,504 | 24,956 | 43 K to 25 K (-41.90 %) |
| Mar 17 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 18.11 | 18,000 | 325,890 | 42,956 | 25 K to 43 K (+72.13 %) |
| Mar 05 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
| Mar 05 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Payment of Exercise | F | 72.80 | 1,767 | 128,638 | 24,956 | 26.7 K to 25 K (-6.61 %) |
| Mar 05 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Buy | M | 0.00 | 3,750 | 0 | 26,723 | 23 K to 26.7 K (+16.32 %) |
| Feb 27 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Feb 27 2015 | ALKS | Alkermes plc. | Ehrich Elliot | EVP, R&D & CMO, Alk ... | Option Exercise | A | 71.23 | 62,500 | 4,451,875 | 62,500 | |
| Jan 27 2010 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | M | 7.36 | 14,869 | 109,436 | 15,245 | |
| Jan 27 2010 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | M | 7.36 | 375 | 2,760 | 0 | |
| Jan 27 2010 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Sell | S | 12.20 | 14,869 | 181,402 | 40,079 | 54.9 K to 40.1 K (-27.06 %) |
| Jan 27 2010 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Buy | M | 7.36 | 14,869 | 109,436 | 54,948 | 40.1 K to 54.9 K (+37.10 %) |
| Jan 27 2010 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Sell | S | 12.20 | 375 | 4,575 | 40,079 | 40.5 K to 40.1 K (-0.93 %) |
| Jan 27 2010 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Buy | M | 7.36 | 375 | 2,760 | 40,454 | 40.1 K to 40.5 K (+0.94 %) |
| Nov 20 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Nov 20 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 9.21 | 40,000 | 368,400 | 40,000 | |
| Nov 06 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Sell | S | 7.98 | 341 | 2,721 | 40,079 | 40.4 K to 40.1 K (-0.84 %) |
| Nov 06 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 8.09 | 159 | 1,286 | 40,420 | 40.6 K to 40.4 K (-0.39 %) |
| Jun 30 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | M | 4.77 | 9,373 | 44,709 | 0 | |
| Jun 30 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 10.69 | 1,649 | 17,628 | 40,579 | 42.2 K to 40.6 K (-3.90 %) |
| Jun 30 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Sell | S | 10.70 | 7,724 | 82,685 | 42,228 | 50 K to 42.2 K (-15.46 %) |
| Jun 30 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Buy | M | 4.77 | 9,373 | 44,709 | 49,952 | 40.6 K to 50 K (+23.10 %) |
| Jun 17 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | M | 0.00 | 3,750 | 0 | 0 | |
| Jun 17 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 9.36 | 1,191 | 11,148 | 40,579 | 41.8 K to 40.6 K (-2.85 %) |
| Jun 17 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Buy | M | 0.00 | 3,750 | 0 | 41,770 | 38 K to 41.8 K (+9.86 %) |
| Jun 03 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 8.11 | 477 | 3,868 | 38,020 | 38.5 K to 38 K (-1.24 %) |
| May 28 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
| May 28 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 8.55 | 65,000 | 555,750 | 65,000 | |
| May 28 2009 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 8.33 | 477 | 3,973 | 38,497 | 39 K to 38.5 K (-1.22 %) |
| Nov 20 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 7.36 | 30,114 | 221,639 | 30,114 | |
| Nov 20 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | D | 7.36 | 30,114 | 221,639 | 0 | |
| Nov 20 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 7.36 | 375 | 2,760 | 375 | |
| Nov 20 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | D | 7.36 | 375 | 2,760 | 0 | |
| Nov 06 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 8.71 | 159 | 1,385 | 38,974 | 39.1 K to 39 K (-0.41 %) |
| Oct 17 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 9.97 | 22,500 | 224,325 | 22,500 | |
| Oct 17 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | D | 9.97 | 22,500 | 224,325 | 0 | |
| Jun 18 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | M | 0.00 | 3,750 | 0 | 3,750 | |
| Jun 18 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 12.73 | 1,191 | 15,161 | 39,133 | 40.3 K to 39.1 K (-2.95 %) |
| Jun 18 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Buy | M | 0.00 | 3,750 | 0 | 40,324 | 36.6 K to 40.3 K (+10.25 %) |
| Jun 03 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Payment of Exercise | F | 12.63 | 477 | 6,025 | 36,574 | 37.1 K to 36.6 K (-1.29 %) |
| May 29 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 12.29 | 45,000 | 553,050 | 45,000 | |
| May 29 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Grant | A | 0.00 | 6,000 | 0 | 37,051 | 31.1 K to 37.1 K (+19.32 %) |
| Apr 02 2008 | ALKS | ALKERMES INC | Ehrich Elliot | SVP, R&D & Chief Me ... | Option Exercise | A | 12.30 | 22,500 | 276,750 | 22,500 |